<?xml version='1.0' encoding='utf-8'?>
<document id="27570216"><sentence text="Variation in high-priority drug-drug interaction alerts across institutions and electronic health records." /><sentence text="The United States Office of the National Coordinator for Health Information Technology sponsored the development of a &quot;high-priority&quot; list of drug-drug interactions (DDIs) to be used for clinical decision support" /><sentence text=" We assessed current adoption of this list and current alerting practice for these DDIs with regard to alert implementation (presence or absence of an alert) and display (alert appearance as interruptive or passive)" /><sentence text="" /><sentence text="We conducted evaluations of electronic health records (EHRs) at a convenience sample of health care organizations across the United States using a standardized testing protocol with simulated orders" /><sentence text="" /><sentence text="Evaluations of 19 systems were conducted at 13 sites using 14 different EHRs" /><sentence text=" Across systems, 69% of the high-priority DDI pairs produced alerts" /><sentence text=" Implementation and display of the DDI alerts tested varied between systems, even when the same EHR vendor was used" /><sentence text=" Across the drug pairs evaluated, implementation and display of DDI alerts differed, ranging from 27% (4/15) to 93% (14/15) implementation" /><sentence text="" /><sentence text="Currently, there is no standard of care covering which DDI alerts to implement or how to display them to providers" /><sentence text=" Opportunities to improve DDI alerting include using differential displays based on DDI severity, establishing improved lists of clinically significant DDIs, and thoroughly reviewing organizational implementation decisions regarding DDIs" /><sentence text="" /><sentence text="DDI alerting is clinically important but not standardized" /><sentence text=" There is significant room for improvement and standardization around evidence-based DDIs" /><sentence text="" /></document>